WO2017100866A1 - Mesure de réponse neuronale - Google Patents

Mesure de réponse neuronale Download PDF

Info

Publication number
WO2017100866A1
WO2017100866A1 PCT/AU2016/051259 AU2016051259W WO2017100866A1 WO 2017100866 A1 WO2017100866 A1 WO 2017100866A1 AU 2016051259 W AU2016051259 W AU 2016051259W WO 2017100866 A1 WO2017100866 A1 WO 2017100866A1
Authority
WO
WIPO (PCT)
Prior art keywords
stimulus
accommodation
neural
signal component
electrode
Prior art date
Application number
PCT/AU2016/051259
Other languages
English (en)
Inventor
Peter Scott Vallack SINGLE
James Hamilton Laird-Wah
Original Assignee
Saluda Medical Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015905289A external-priority patent/AU2015905289A0/en
Application filed by Saluda Medical Pty Ltd filed Critical Saluda Medical Pty Ltd
Publication of WO2017100866A1 publication Critical patent/WO2017100866A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0541—Cochlear electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36036—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the outer, middle or inner ear
    • A61N1/36038—Cochlear stimulation
    • A61N1/36039—Cochlear stimulation fitting procedures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/12—Audiometering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/389—Electromyography [EMG]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
    • H04R2225/00—Details of deaf aids covered by H04R25/00, not provided for in any of its subgroups
    • H04R2225/67—Implantable hearing aids or parts thereof not covered by H04R25/606

Definitions

  • the present invention relates to the measurement of the auditory response and for example to a method of electrically monitoring a stapedius reflex or the like, using implanted cochlear implant electrodes, to determine a patient's comfort threshold.
  • the present disclosure additionally or alternatively provides for dynamic mapping of neural excitation to provide for stimulus generation to occur in a dynamic manner to produce a desired neural response while allowing for neural accommodation to a stimulation history.
  • Cochlear implants apply electrical stimuli of variable intensity to evoke the sensation of sound. This is determined by using a mapping from acoustic sound intensity (loudness) to electrical stimulus intensity. These maps are typically parameterised by measuring threshold (T) and comfort (C) levels on each electrode, for each patient. When fitting cochlear implants it is therefore typical to obtain the implant recipient's input regarding their perceptions which arise in response to applied stimuli. However in some cases, such as when fitting pre-lingual infants or when fitting adults unable to provide reliable behavioural measures, limited or no subjective input can be obtained from the implant recipient.
  • the threshold (T) level is the least amount of electrical current necessary for a person to perceive a sound
  • the comfort (C) level is the amount of electrical current which results in a loud but comfortable perception.
  • the C level, or analogue thereof, in some applications is instead referred to as a Most Comfortable Loudness level (abbreviated as MCL or M level).
  • MCL Most Comfortable Loudness level
  • Threshold can be measured using auditory brainstem response but it is expensive and time consuming.
  • comfort level is more difficult to measure.
  • comfort level can vary widely between individuals, depending for example on the cause of deafness, and is thus important to measure for each individual.
  • one approach is to measure the neural response to stimuli in order to determine a threshold level of stimulation at which evoked neural responses first arise on the auditory nerve.
  • This level of stimulation does not always precisely match the recipient's perceptions, but can at least serve as an approximation of the correct T level. However, no such threshold can be observed from neural response
  • the stapedius reflex In order to objectively generate an estimate for the C level, the stapedius reflex has been considered.
  • the stapedius reflex involves contraction of the stapedius muscle in the middle ear in response to loud sounds, and thus may serve as a proxy for the threshold at which perceived sound becomes uncomfortably loud.
  • the stapedius reflex can be seen intra- operatively, but the cochlear implant electrode current required for the stapedius reflex to become visible exceeds the patient's C level; i.e. by the time the stapedius reflex can be seen the stimulus level is too high and the perceived sound too loud.
  • EESRs Electrically elicited stapedius reflexes
  • EESRs electrically elicited stapedius reflexes
  • EESRs recorded by needle electrodes in human patients show latencies on the order of around 5- 10ms, which increase in amplitude and decrease in latency as the current continues to increase above the stapedius reflex threshold.
  • These methods of assessing the stapedius reflex threshold however require separate surgical or clinical tools which are moderately to significantly invasive and return only a single measurement.
  • the present invention provides a method of determining a cochlear implant recipient's comfort level, the method comprising:
  • the present invention provides a device configured to determine a cochlear implant recipient's comfort level, the device comprising:
  • a stimulation controller configured to control the delivery of electrical stimuli from at least one electrode of an implanted cochlear implant to the cochlear nerve;
  • a recording controller configured to control the recording by at least one electrode of the implanted cochlear implant of recordings of neural responses evoked on the cochlear nerve by the electrical stimuli;
  • the present invention provides a computing device configured to carry out the method of the first aspect.
  • inspecting the recordings to detect a diagnostic signal component may comprise inspecting a time period of substantially 1-20 ms after the stimulus, and/or a time period 1-7 ms after the stimulus.
  • Inspecting the recordings to detect a diagnostic signal component may in some embodiments comprise inspecting a time period of substantially 4-7 ms after the stimulus and/or a time period of substantially 1-3 ms after the stimulus and/or a time period of substantially 10-15 ms after the stimulus.
  • a recording obtained from a basal electrode is compared to a recording obtained from a more apical electrode in order to discriminate a diagnostic signal component.
  • a recording obtained from an extra- cochlear electrode may in some embodiments be compared to a recording obtained from an intra-cochlear electrode in order to discriminate a diagnostic signal component.
  • the comparison may for example be of either or both of a time period of substantially 2-4 ms after the stimulus in each such recording, and a time period of substantially 4-7 ms after the stimulus in each such recording.
  • a relatively stronger signal component in the basal electrode recording in the time period of substantially 2-4 ms after the stimulus coinciding with a relatively stronger signal component in the apical electrode recording in the time period of substantially 4-7 ms after the stimulus may be taken to be a diagnostic signal component.
  • a latency of a signal component is determined in order to discriminate a diagnostic signal component.
  • a reduction in latency with an increase in stimulus current may be taken to be a diagnostic signal component.
  • the diagnostic signal component sought may arise from activation of a neural or muscular system which presents a useful proxy for comfort level.
  • the diagnostic signal component may arise from the stapedius reflex.
  • the stimulating and recording are performed repeatedly to improve the determination of the comfort level.
  • the stimulating and recording may in some embodiments be performed in the range 1 - 300 Hz, such as at a rate below 10 Hz, at a rate of 2 Hz, at a rate of 33 Hz or at a rate above 100 Hz.
  • determination of a comfort level may comprise
  • the diagnostic signal component may comprise any one, some or all of the signal characteristics discussed herein, combined in any suitable manner.
  • Determining the comfort level from an observed onset of the diagnostic signal component may comprise defining the comfort level as being the same as the stimulus current at which onset of the diagnostic signal component occurs.
  • the comfort level may be defined as a different current level, calculated in any suitable manner from the stimulus current at which onset of the diagnostic signal component occurs.
  • the comfort level may be determined in accordance with the present invention in respect of each of a plurality of channels, a plurality of electrodes, and/or a plurality of frequency bands in order to yield a spectral mapping of comfort level.
  • the present invention provides a method of dynamically adjusting neural stimuli to compensate for neural accommodation, the method comprising:
  • the present invention provides a device for dynamically adjusting neural stimuli to compensate for neural accommodation, the device comprising:
  • a recording medium holding data defining a map of neural accommodation; a signal processor for taking an input signal and determining a stimulus therefrom, and for adjusting the stimulus by reference to a stimulation history and the map of neural
  • Embodiments of the fourth and fifth aspects of the present invention may thus provide a system for compensating for accommodation using a dynamic map.
  • the technique for doing so may in some embodiments comprise a static map and an accommodation model.
  • the accommodation model may in some embodiments be fitted and/or adjusted using measurements of ECAPs.
  • ECAPs may be measured after every stimulus during normal use of the neurostimulator, or after selected stimuli during normal use.
  • the accommodation model may in some embodiments be fitted and/or adjusted using measurements of ECAPs at a time of fitting or installation of the neurostimulator, by use of probe stimuli to evoke the ECAPs.
  • the probe stimuli may comprise a constant amplitude train, or may be adjusted to produce constant amplitude ECAPs.
  • the probe stimuli may comprise a pseudorandom sequence.
  • the probe stimuli sequence may be delivered on multiple electrodes for MIMO accommodation mapping.
  • the accommodation model may in some embodiments adjust a static stimulation map.
  • the adjustment may comprise scaling T while leaving C unchanged.
  • the adjustment may comprise scaling total stimulus intensity so that both T and C are adjusted.
  • Other embodiments may select different map curves depending on state or stimulation history.
  • the accommodation model may in some embodiments apply to a single electrode, and may take into account only the stimulation history of that electrode. Alternatively, the accommodation model may in some embodiments reflect a stimulation history of more than one electrode.
  • the accommodation model may in some embodiments comprise a linear filter.
  • An input of the linear filter may be clamped, or a state variable of the filter may be clamped.
  • An input to the accommodation model may in some embodiments comprise stimulus current, or in other embodiments stimulus charge such as in the case of variable pulse widths.
  • Embodiments of the fourth and fifth aspects of the present invention may provide a system for compensating for accommodation in a cochlear implant, a deep brain stimulator, a spinal cord stimulator, a retinal or optic nerve stimulator, or the like.
  • Other embodiments of the fourth and fifth aspects of the present invention may provide a system for achieving consistent neural response in the presence of accommodation by using adaptive filtering.
  • the adaptive filter may be trained using the difference between desired and recorded characteristic, such as ECAP output.
  • filter training is suppressed during periods without stimulation.
  • the filter produces zero output when stimulation is not desired.
  • the filter is affine for nonzero inputs.
  • the adaptive filtering may be applied in a SISO manner in respect of a single electrode or a single channel, or in a MTMO manner in respect of a plurality of electrodes or channels.
  • the present invention provides a method of training a system for compensating for neural accommodation, the method comprising measuring neural
  • an ECAP characteristic may be measured for such training.
  • the ECAP characteristic may comprise one or more of: amplitude of a component, a detector output, a latency of a component.
  • FIG. 1 For embodiments of the invention, further embodiments of the invention provide for mapping the therapy variable to a desired ECAP characteristic.
  • the map of the therapy variable to the desired ECAP characteristic therapy may for example be combined with a percept-to-ECAP map for sensory stimulation, combined with a loudness-to-ECAP map for cochlear implants or auditory brainstem implants, or combined with a light-to-ECAP map for retinal prostheses
  • Figure 1 illustrates a cochlear implant system in accordance with one embodiment of the present invention
  • Figure 2 is a block diagram of an implanted neurostimulator
  • Figure 3 is a schematic illustrating interaction of the implanted stimulator with a nerve;
  • Figures 4-8 show the signals demonstrating the stapedius reflex;
  • Figure 9 illustrates a prior cochlear implant architecture
  • Figure 10 illustrates a prior cochlear implant mapping
  • Figure 11 illustrates prior clinical mapping adjustment estimations to compensate for broad spectrum loudness summation
  • Figure 12 illustrates prior clinical mapping adjustment estimations to compensate for pre- lingual subjects
  • Figure 13 illustrates the nature of neural adaptation or accommodation
  • Figure 14 is a schematic of data flow in a cochlear implant
  • Figure 15 is a schematic of an embodiment of the invention using a dynamic map for neural adaptation compensation
  • Figure 16 is a schematic of an embodiment of the invention using a dynamic map for neural adaptation compensation for each electrode
  • Figure 17 is a schematic of an embodiment of the invention using a dynamic map for neural adaptation compensation for each electrode
  • Figure 18 is a schematic of an embodiment of the invention using a MIMO dynamic map for neural adaptation compensation
  • Figure 19 is a schematic of an embodiment of the invention using a MIMO dynamic map for neural adaptation compensation.
  • Figure 20 is a schematic of an embodiment of the invention using an adaptive filter for neural adaptation compensation.
  • FIG. 1 illustrates a cochlear implant system 10 in accordance with one embodiment of the present invention.
  • the system 10 comprises an external sound processing device 12, an external transceiver coil 14, an implanted transceiver coil and pulse generator 16 in
  • Processor unit 12 controls the delivery of stimuli to the electrodes 20 in order to deliver electrical stimuli to the cochlea and evoke neural responses upon the cochlear nerve 22 for perception by the brain as a supplement to or substitute for the normal hearing mechanism for the hearing impaired.
  • Electrodes 20 are also in close proximity to the middle ear, in particular the stapes 24 and stapedius muscle (not shown).
  • FIG. 2 is a block diagram of a neurostimulator 100.
  • Module 1 10 contains a battery 112 and a telemetry module 114.
  • any suitable type of transcutaneous communication such as infrared (IR), electromagnetic, capacitive and inductive transfer, may be used by telemetry module 114 to transfer power and/or data between an external device and the electronics module 110.
  • Module controller 116 has an associated memory 118 storing patient settings 120, control programs 122 and the like. Controller 116 controls a pulse generator 124 to generate stimuli in the form of current pulses in accordance with the patient settings 120 and control programs 122. Electrode selection module 126 switches the generated pulses to the appropriate electrode(s) of electrode array 150, for delivery of the current pulse to the tissue surrounding the selected electrode. Measurement circuitry 128 is configured to capture measurements of neural responses sensed at sense electrode(s) of the electrode array as selected by electrode selection module 126. In the case of the cochlear implant system 10 shown in Figure 1, the components of module 110 can be distributed in any suitable manner between the external sound processing device 12 and the implanted transceiver coil and pulse generator 16, and the present invention encompasses such variations in architecture.
  • FIG. 3 is a schematic illustrating electrical interaction of the implanted stimulator 100 with a nerve 180, in this case the auditory nerve and other proximal tissue including the stapedius muscle.
  • Electrode selection module 126 selects a stimulation electrode 2 of electrode array 150 to deliver an electrical current pulse to surrounding tissue including nerve 180, and also selects a return electrode 4 of the array 150 for stimulus current recovery to maintain a zero net charge transfer.
  • the device 100 is further configured to sense the existence and intensity of
  • any electrodes of the array 150 may be selected by the electrode selection module 126 to serve as measurement electrode 6 and measurement reference electrode 8.
  • Measurement circuitry 128, which for example may operate in accordance with the teachings of International Patent Application Publication No. WO2012155183 by the present applicant, the content of which is incorporated herein by reference.
  • the present invention recognises that when measuring the evoked response with a low artefact amplifier, the stapedius reflex can be seen in the recordings obtained from the cochlear implant electrodes, and the stapedius reflex arises approximately 5ms after stimulation and temporally separate to evoked response on the auditory nerve.
  • the stapedius reflex has an onset that, in the recordings obtained from the cochlear implant electrodes, appears gradually with increasing stimulus current. The gradual onset of the stapedius reflex cannot be seen visually by surgeons intra-operatively. Also, for a patient who has their implant surgery complete, the stapedius reflex cannot be seen at all.
  • Figures 4-8 show recordings obtained from cochlear implant electrodes in accordance with the present invention, and demonstrating the stapedius reflex. Specifically, Figures 4-8 illustrate the evolution of the observed stapedius reflex signal with changes in stimulus current.
  • the stapedius reflex appears gradually in response to increasing stimulus currents.
  • the function of the stapedius muscle is to separate the ossicles slightly, which serves to reduce the signal to the cochlea but not to the point of total attenuation.
  • the present invention recognises that the cochlear implant electrodes can be exploited to perform electromyography to sense this behaviour of the stapedius muscle electrically.
  • This observable signal is referred to herein as the evoked stapedius electrical response (ESER).
  • ESER evoked stapedius electrical response
  • the aforementioned EESR is a muscle response from electrical stimulation, while the ESER is an electrical measurement following EESR. This requires a suitable low-artefact amplifier as described above in relation to Figures 1-3.
  • the present invention further recognises that the ESER forms a useful measure or indicator of a patient's C level.
  • Some embodiments of the present invention further provide for determining comfort level from an observed ESER onset level, by comparison to previous measurements of an average or typical ratio or relationship between ESER onset and C levels across a control group of lingual patients. The ratio or relationship may then be applied to deduce a non-lingual patient's comfort level from the observed ESER onset of that patient.
  • Figures 4-8 cover stim at 33Hz and 2Hz under otherwise identical conditions.
  • Figures 4-5 show recordings obtained from several electrodes of the cochlear implant 10, at a given stimulus current.
  • Figure 4 illustrates respective recordings 402, 404, 406, 408 obtained from electrodes El, E5, E8 and E14 following the application of a 1.9 mA stimulus
  • Figure 5 illustrates recordings 502, 504, 506, 508 obtained from electrodes El, E5, E8 and E14 following the application of a 1.8 mA stimulus.
  • Figure 4 is to be contrasted with Figure 5, in which a slightly smaller stimulus current of 1.8 mA continues to give rise to ECAPs during time period 512, but gives rise to a much reduced signal component during time period 514. This indicates that a stimulus current in the vicinity of 1.8 mA - 1.9 mA crosses a threshold for the bioelectrical response in time period 414/514.
  • the present invention pertains specifically to making observations of those signal components within time period 414/514 and using them as a means to estimate a patient's comfort level or an analogue thereof such as the M level.
  • a further candidate for serving as a diagnostic is also revealed in the different behaviour of the recordings from different electrodes.
  • electrode El was outside the round window, and hence a different electrical distance from the stapedius as compared to electrodes E5, E8, E14.
  • time period 416 arising around 2.6ms after stimulus, the recording is larger in amplitude on El than the other electrodes, whereas in time period 414 the recording from El is smaller than the other electrodes.
  • This inter-electrode variation thus presents a further signal characteristic by which the ESER may be discriminated from other signal components.
  • Figures 6-8 show how the recordings obtained from electrode E8 of the cochlear implant 10 change with stimulus current.
  • the recordings 602, 604, 606, 608, 610, 612, 614, 616 are obtained in response to electrical stimuli delivered at current levels of 0.9 mA, 1.3 mA, 1.6 mA, 1.6 mA, 1.8 mA, 1.9 mA, 2.0 mA, 2.2 mA, respectively, at 33 Hz.
  • ECAPs are evoked in the time period 0-2ms, but no signal components are evident in the time period 4-7 ms.
  • recordings 608-616 exhibit increasing signal components in the time period 4-7 ms, consistent with gradual onset of a stapedius reflex.
  • Figure 7 provides a longer duration section of another set of recordings, obtained over a duration of 20 ms, to show later components of the recorded signals in response to the delivery of stimuli at 2 Hz.
  • the threshold for the onset of a response in the 4-7 ms time period can be seen to be between 1.5 mA and 1.8 mA.
  • a 6ms component appears at 1.4mA.
  • Figures 6 - 8 further illustrate that a latency of a peak of the signal component in the 4-7 ms range decreases with increasing current.
  • the latency of such a signal component may also be used as a diagnostic for present purposes.
  • 1.8mA though, another component appears and swamps it - this second component grows but its latency doesn't change.
  • There is a component at 2.6ms which appears at the same or slightly lower current, which may be part of the reflex loop.
  • Figure 7 also exhibits subtler components in the time period 10-15ms following the stimulus, at stimulus levels >1.8mA, which aren't seen when stimulating at 33 Hz.
  • the stimulation threshold of nerve fibres varies depending on their prior exposure to stimulation fields. These accommodation effects can take the form of an increase or decrease in the stimulation threshold, and multiple accommodation effects can be present simultaneously. These may take periods from
  • milliseconds to minutes to manifest during continuous stimulation may take from
  • a block diagram of a conventional cochlear implant is shown in Figure 9.
  • a microphone signal is amplified, then fed via a sensitivity control to an AGC.
  • the AGC output then feeds an array of band-pass filters (BPF), each tuned to a different frequency.
  • BPF band-pass filters
  • the energy of the output of each of these filters are detected and converted to a logarithmic scale (DET).
  • DET logarithmic scale
  • the signal amplitude is mapped to a charge value (MAP) which then controls a stimulator which delivers charge metered non-overlapping pulses to the cochlea.
  • MAP charge value
  • a conventional mapping between sound intensity and stimulation intensity is shown in Figure 10.
  • a sound below a certain amplitude SPL(T) produces no stimulation. If the stimulation intensity exceeds SPL(T) then it is mapped into a logarithmic current growth curve up to SPL(C) corresponding to stimulation at Q(C). For sound pressure above SPL(C) the stimulation does not increase. This mapping occurs for each channel, and thus for each electrode.
  • the SPL(T) and SPLIC) are controlled by the gain of the amplifier, the sensitivity control and the AGC.
  • the Q(C) and Q(T) values are set using a process called "psychophysical mapping", or just “psychophysics".
  • psycho-physics each electrode is stimulated at a fixed rate, typically 1 KHz.
  • T level The point at which a recipient can just detect the stimulation is called “T level”.
  • the signal level is increased until the patient finds that it is the maximum value that remains comfortable or "C level”. This is repeated on each electrode.
  • This process is equivalent to playing a single-tone sine wave into the speech processor at SPL(T) and then adjusting Q(T) until it can just be heard. Then presenting a tone at SPL(C) and increasing the charge till it is just comfortable.
  • a first problem with traditional psycho-physics is that when complex sound across a broader spectrum is played into a speech processor, it sounds a lot louder than the loudness of a single tone or psycho- physics stimulation train of corresponding amplitude.
  • Q(C) Q(PSY C).
  • a second problem with traditional psychophysics is that it is unsuitable for people without language, such as infants.
  • To find the Q(T) and Q(C) for infants one can measure the evoked response of the cochlea using electrical measurement of signals evoked on the nerve, sometimes called neural response telemetry ( RT).
  • RT neural response telemetry
  • the measurable level is usually well above the true threshold, between Q(T) and Q(C), and a second arbitrary scale factor B must be used as shown in Figure 12.
  • the present invention recognises that a first phenomenon that explains the
  • FIG. 13 An example of adaptation is shown in Figure 13.
  • the ECAP evoked by each stimulus is diminished over time as shown in the lower plot of Figure 13. This is a case of inhibitory accommodation, where the stimulation threshold is increased; excitatory
  • accommodation may also occur and causes the stimulation threshold to decrease.
  • Cochlear implant speech processing algorithms continuously select different sequences of stimuli to deliver in order to approximate the incoming sound signal. This uses a stimulation map for each electrode, which is determined statically from T and C when the patient is fitted. The map determines the correct stimulus intensity to deliver in order to evoke the sensation of a given sound intensity (loudness).
  • the nerve fibres near each electrode will be subjected to varying patterns of stimuli. In the presence of accommodation effects, their thresholds will be constantly changing. A static stimulation map assumes that these thresholds are unchanging, and so will not provide the desired neural recruitment.
  • a dynamic map is used to compensate for accommodation effects. This map takes into account the stimuli which have been previously delivered to each electrode, and can then be used to determine the appropriate stimulus intensity to achieve a desired loudness value.
  • Figure 14 shows a schematic of data flow in a cochlear implant.
  • Audio input is processed by a speech processor, which schedules stimuli on different electrodes and with different loudnesses to reproduce the input sound.
  • the stimulation map maps the desired loudness of a stimulus to an electrical stimulus intensity for that stimulation electrode.
  • a pulse generator then delivers the stimuli to the desired electrode.
  • the present invention recognises that a dynamic mapping can be implemented by adjusting the stimulation map in real time depending on the neural accommodation arising from recently applied stimuli.
  • a dynamic map requires a model of the accommodation effects expected to arise from given recently applied stimuli.
  • This model may be fitted to the patient during initial implant fitting, by delivering a sequence of probe stimuli and recording the ensuing evoked compound action potentials (ECAPs) using an amplifier and ADC.
  • ECAPs evoked compound action potentials
  • the evoked action potentials indicate the level of achieved neural recruitment from each stimulus, allowing accommodation effects to be measured.
  • An example of a probe sequence is a periodic train of identical pulses.
  • Probes may also be adjusted to achieve a constant recruitment and/or constant ECAP amplitude.
  • Random and pseudorandom sequences are also useful for system identification.
  • the common engineering techniques of model identification and channel estimation are applicable to this problem.
  • FIG. 15 A first embodiment of the present invention for implementation of a dynamic map is shown in Figure 15.
  • a model estimates the deviation in threshold as a result of prior stimuli. This threshold estimate is used to scale the stimulus intensity determined with a traditional static map.
  • T(t) pG(max(I(t) - R, 0)) + To
  • I(t) is the delivered stimulus waveform
  • R is a stimulus intensity at which accommodation begins to occur
  • G() is a single-pole low-pass filter, whose gain models the degree of
  • d. p is +1 for an excitatory and -1 for an inhibitory accommodation process, e. To is the unaccommodated threshold.
  • the parameters for G and p can be determined by measuring the step response:
  • the dynamic map of Figure 15 estimates the threshold of the target nerves and scales the total stimulation; i.e. it effectively adjusts both the T and C levels of the map.
  • a more advanced dynamic map may adjust the T level according to the model' s threshold estimate whilst leaving the C level constant.
  • a dynamic map may also switch between mapping curves depending on the state of the model.
  • Simple models may treat each electrode independently, assuming that stimulation on one electrode does not affect the thresholds at nearby electrodes.
  • Figures 16 and 17 show such systems, in which a separate, independent dynamic map is used for each of N electrodes.
  • Adjustment of T and C levels is based on NRT measurement of adaption. By measuring the NRT thresholds on individual electrodes during live speech, it is possible to measure the level of their adaption. This can then be used to adjust the T and C levels.
  • MIMO model techniques are used to model interactions between nearby electrodes.
  • Figures 18 and 19 show embodiments where the dynamic model is split. A common model is used which takes into account the N different stimulus waveforms' history, and the N model outputs are fed to the per-channel dynamic mapping system.
  • Figure 19 shows that the overall level of stimulation, being the primary contributor to loudness summation, can also be calculated by combining the outputs of the individual detectors, and then automatically adjusting the mapping processes.
  • the loudness summation in Figure 19 may in another embodiment (not shown) be output to the AGC for AGC control.
  • an adaptive filter is used to determine the correct stimulus intensity in the presence of neural accommodation.
  • the desired stimulation is mapped to, or expressed in, some characteristic of the ensuing ECAP, such as the amplitude of an ECAP component, the latency of an ECAP component, or the output of a detector applied to the ECAP waveform.
  • the filter estimates the correct stimulus intensity to produce the desired ECAP characteristic.
  • the ensuing ECAP characteristic is measured. The difference between the desired and actual characteristic value forms an error term which is used to adapt the filter.
  • any of the existing body of work in adaptive filters may be adapted to this task, such as least mean squares filtering, recursive least squares filtering, et cetera. It is desirable that the filter have an affine characteristic which represents the threshold current required to begin producing neural recruitment and hence an ECAP.
  • the pulse generator When no stimulus is desired on the selected channel, the pulse generator is not activated, regardless of the filter output.
  • the filter's internal state is still updated; this may be performed on every timestep, or the update for several timesteps may be applied immediately before the next filter prediction is required.
  • the filter's adaptation may be inhibited, and no ECAP recorded, during periods when no stimulus is delivered on that channel.
  • parts of the filter model may be selectively updated depending on the stimulation pattern.
  • FIG. 20 An example of such a system, applied to a cochlear implant, is shown in Figure 20.
  • the traditional map from loudness to stimulus intensity is replaced with one from loudness to desired ECAP amplitude.
  • the ECAP amplitude is the controlled characteristic.
  • the ECAP detector may take a peak-to-peak voltage measurement, take the dot product of the ECAP recording with a desired filter kernel, or measure any other desired characteristic of the ECAP.
  • An adaptive filter may also be used in a MTMO configuration, in which the filter has N inputs and N outputs.
  • the desired ECAP levels on each of N channels are fed in simultaneously; typically, this will be zero on all bar one channel. Similarly, only one channel's output will usually be delivered using the pulse generator on each time step.
  • the filter adaptation may be suppressed on channels which are not delivering stimulation and recording ECAPs.
  • a dynamic map or adaptive filter may be configured or trained during patient fitting, using training-specific stimulation sequences, with the determined settings being retained during subsequent therapeutic stimulation. Maps and filters may also be configured or trained during regular speech processing stimulation. ECAPs can be recorded from therapeutic/sensory stimuli, rather than specific probe stimuli. These adjustments may be performed on every stimulus, or only intermittently on some stimuli or during some periods of stimulation.
  • This method may also use multi-dimensional maps to control multiple parameters simultaneously. These maps may have multiple inputs: for example, a visual prosthesis may control both brightness and spot size of a stimulus. These maps may have multiple outputs: for example, the pulse width and current of a stimulus may be independently controlled.

Abstract

La présente invention concerne un procédé de détermination d'un niveau de confort d'un receveur d'implant cochléaire. Des stimuli électriques sont appliqués à la cochlée. Au moins une électrode de l'implant cochléaire implanté est utilisée pour obtenir des enregistrements de réponses neuronales évoquées sur le nerf cochléaire par les stimuli électriques. Les enregistrements sont inspectés pour détecter une composante de signal diagnostique, telle que l'apparition d'un réflexe stapédien. Le niveau de confort est déterminé à partir de la composante de signal diagnostique. L'invention concerne en outre un procédé d'ajustement dynamique de stimuli neuronaux pour compenser l'accommodation neuronale. Un stimulus est ajusté en référence à un historique de stimulation et une carte d'accommodation neuronale, puis appliqué à un tissu neuronal.
PCT/AU2016/051259 2015-12-18 2016-12-19 Mesure de réponse neuronale WO2017100866A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2015905289A AU2015905289A0 (en) 2015-12-18 Measurement of Auditory Response
AU2015905289 2015-12-18

Publications (1)

Publication Number Publication Date
WO2017100866A1 true WO2017100866A1 (fr) 2017-06-22

Family

ID=59055455

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2016/051259 WO2017100866A1 (fr) 2015-12-18 2016-12-19 Mesure de réponse neuronale

Country Status (1)

Country Link
WO (1) WO2017100866A1 (fr)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10357656B2 (en) * 2016-07-12 2019-07-23 Cochlear Limited Hearing prosthesis programming
US10406368B2 (en) 2016-04-19 2019-09-10 Boston Scientific Neuromodulation Corporation Pulse generator system for promoting desynchronized firing of recruited neural populations
WO2019229162A1 (fr) * 2018-05-31 2019-12-05 Entic Research And Training Center Bvba Procédé de dérivation d'informations destiné à l'ajustement d'un implant cochléaire
US20200269047A1 (en) * 2019-02-21 2020-08-27 Envoy Medical Corporation Implantable cochlear system with integrated components and lead characterization
US10926092B2 (en) 2018-01-08 2021-02-23 Boston Scientific Neuromodulation Corporation Automatic adjustment of sub-perception therapy in an implantable stimulator using detected compound action potentials
US10940316B2 (en) 2010-06-18 2021-03-09 Cardiac Pacemakers, Inc. Methods and apparatus for adjusting neurostimulation intensity using evoked responses
US10974042B2 (en) 2018-03-26 2021-04-13 Boston Scientific Neuromodulation Corporation System and methods for heart rate and electrocardiogram extraction from a spinal cord stimulation system
US11040202B2 (en) 2018-03-30 2021-06-22 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device
EP3838330A1 (fr) * 2019-12-19 2021-06-23 Oticon Medical A/S Système d'implant cochléaire d'enregistrement d'ecap amélioré
US11129989B2 (en) 2018-06-21 2021-09-28 Medtronic, Inc. ECAP based control of electrical stimulation therapy
US11129987B2 (en) 2017-10-04 2021-09-28 Boston Scientific Neuromodulation Corporation Adjustment of stimulation in a stimulator using detected evoked compound action potentials
US11129991B2 (en) 2018-06-21 2021-09-28 Medtronic, Inc. ECAP based control of electrical stimulation therapy
US11179567B2 (en) 2019-12-19 2021-11-23 Medtronic, Inc. Hysteresis compensation for detection of ECAPs
US11202912B2 (en) 2019-12-19 2021-12-21 Medtronic, Inc. Posture-based control of electrical stimulation therapy
US11241580B2 (en) 2018-06-01 2022-02-08 Boston Scientific Neuromodulation Corporation Artifact reduction in a sensed neural response
US11259733B2 (en) 2019-03-29 2022-03-01 Boston Scientific Neuromodulation Corporation Neural sensing in an implantable stimulator device during the provision of active stimulation
US11439825B2 (en) 2019-12-19 2022-09-13 Medtronic, Inc. Determining posture state from ECAPs
US11471689B2 (en) 2020-12-02 2022-10-18 Envoy Medical Corporation Cochlear implant stimulation calibration
US11504526B2 (en) 2019-05-30 2022-11-22 Boston Scientific Neuromodulation Corporation Methods and systems for discrete measurement of electrical characteristics
US11547855B2 (en) 2019-10-25 2023-01-10 Medtronic, Inc. ECAP sensing for high frequency neurostimulation
US11564046B2 (en) 2020-08-28 2023-01-24 Envoy Medical Corporation Programming of cochlear implant accessories
US11612751B2 (en) 2017-08-11 2023-03-28 Boston Scientific Neuromodulation Corporation Stimulation configuration variation to control evoked temporal patterns
US11623095B2 (en) 2019-06-20 2023-04-11 Boston Scientific Neuromodulation Corporation Methods and systems for interleaving waveforms for electrical stimulation and measurement
US11633591B2 (en) 2021-02-23 2023-04-25 Envoy Medical Corporation Combination implant system with removable earplug sensor and implanted battery
US11633138B2 (en) 2019-03-29 2023-04-25 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device in the presence of stimulation artifacts
US11697019B2 (en) 2020-12-02 2023-07-11 Envoy Medical Corporation Combination hearing aid and cochlear implant system
US11707626B2 (en) 2020-09-02 2023-07-25 Medtronic, Inc. Analyzing ECAP signals
US11806531B2 (en) 2020-12-02 2023-11-07 Envoy Medical Corporation Implantable cochlear system with inner ear sensor
US11839765B2 (en) 2021-02-23 2023-12-12 Envoy Medical Corporation Cochlear implant system with integrated signal analysis functionality
US11857793B2 (en) 2020-06-10 2024-01-02 Medtronic, Inc. Managing storage of sensed information
US11865339B2 (en) 2021-04-05 2024-01-09 Envoy Medical Corporation Cochlear implant system with electrode impedance diagnostics
US11896828B2 (en) 2020-10-30 2024-02-13 Medtronic, Inc. Implantable lead location using ECAP
US11931582B2 (en) 2019-10-25 2024-03-19 Medtronic, Inc. Managing transient overstimulation based on ECAPs
US11938323B2 (en) 2018-03-12 2024-03-26 Boston Scientific Neuromodulation Corporation Neural stimulation with decomposition of evoked compound action potentials

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6157861A (en) * 1996-06-20 2000-12-05 Advanced Bionics Corporation Self-adjusting cochlear implant system and method for fitting same
US20050261748A1 (en) * 2004-05-10 2005-11-24 Cochlear Limited Cochlear implant fitting
WO2012155188A1 (fr) * 2011-05-13 2012-11-22 National Ict Australia Ltd Méthode et appareil pour commander un stimulus neuronal e
US20120303095A1 (en) * 2011-05-24 2012-11-29 Med-El Elektromedizinische Geraete Gmbh Progressive Parameter Scan for Cochlear Implants
US20150018699A1 (en) * 2012-01-30 2015-01-15 The Regents Of The University Of California System and methods for closed-loop cochlear implant

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6157861A (en) * 1996-06-20 2000-12-05 Advanced Bionics Corporation Self-adjusting cochlear implant system and method for fitting same
US20050261748A1 (en) * 2004-05-10 2005-11-24 Cochlear Limited Cochlear implant fitting
WO2012155188A1 (fr) * 2011-05-13 2012-11-22 National Ict Australia Ltd Méthode et appareil pour commander un stimulus neuronal e
US20120303095A1 (en) * 2011-05-24 2012-11-29 Med-El Elektromedizinische Geraete Gmbh Progressive Parameter Scan for Cochlear Implants
US20150018699A1 (en) * 2012-01-30 2015-01-15 The Regents Of The University Of California System and methods for closed-loop cochlear implant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HUGHES, M.: "Fundamentals of Clinical ECAP Measures in Cochlear Implants Part 2: Measurement Techniques and Tips.", AUDIOLOGY, 2006, pages 1 - 7, Retrieved from the Internet <URL:http://www.audiologyonline.com/articles/fundamentals-clinical-ecap-measures-in-965-965>> [retrieved on 20170418] *

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10940316B2 (en) 2010-06-18 2021-03-09 Cardiac Pacemakers, Inc. Methods and apparatus for adjusting neurostimulation intensity using evoked responses
US11577083B2 (en) 2010-06-18 2023-02-14 Cardiac Pacemakers, Inc. Methods and apparatus for adjusting neurostimulation intensity using evoked responses
US10406368B2 (en) 2016-04-19 2019-09-10 Boston Scientific Neuromodulation Corporation Pulse generator system for promoting desynchronized firing of recruited neural populations
US10960211B2 (en) 2016-04-19 2021-03-30 Boston Scientific Neuromodulation Corporation Pulse generator system for promoting desynchronized firing of recruited neural populations
US11623097B2 (en) 2016-04-19 2023-04-11 Boston Scientific Neuromodulation Corporation Pulse generator system for promoting desynchronized firing of recruited neural populations
US10357656B2 (en) * 2016-07-12 2019-07-23 Cochlear Limited Hearing prosthesis programming
US11612751B2 (en) 2017-08-11 2023-03-28 Boston Scientific Neuromodulation Corporation Stimulation configuration variation to control evoked temporal patterns
US11129987B2 (en) 2017-10-04 2021-09-28 Boston Scientific Neuromodulation Corporation Adjustment of stimulation in a stimulator using detected evoked compound action potentials
US11786737B2 (en) 2018-01-08 2023-10-17 Boston Scientific Neuromodulation Corporation Automatic adjustment of sub-perception therapy in an implantable stimulator using detected compound action potentials
US10926092B2 (en) 2018-01-08 2021-02-23 Boston Scientific Neuromodulation Corporation Automatic adjustment of sub-perception therapy in an implantable stimulator using detected compound action potentials
US11938323B2 (en) 2018-03-12 2024-03-26 Boston Scientific Neuromodulation Corporation Neural stimulation with decomposition of evoked compound action potentials
US11571566B2 (en) 2018-03-26 2023-02-07 Boston Scientific Neuromodulation Corporation System and methods for heart rate and electrocardiogram extraction from a spinal cord stimulation system
US11850418B2 (en) 2018-03-26 2023-12-26 Boston Scientific Neuromodulation Corporation System and methods for heart rate and electrocardiogram extraction from a spinal cord stimulation system
US10974042B2 (en) 2018-03-26 2021-04-13 Boston Scientific Neuromodulation Corporation System and methods for heart rate and electrocardiogram extraction from a spinal cord stimulation system
US11931579B2 (en) 2018-03-30 2024-03-19 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device
US11040202B2 (en) 2018-03-30 2021-06-22 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device
US11607549B2 (en) 2018-03-30 2023-03-21 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device
WO2019229162A1 (fr) * 2018-05-31 2019-12-05 Entic Research And Training Center Bvba Procédé de dérivation d'informations destiné à l'ajustement d'un implant cochléaire
US11241580B2 (en) 2018-06-01 2022-02-08 Boston Scientific Neuromodulation Corporation Artifact reduction in a sensed neural response
US11129989B2 (en) 2018-06-21 2021-09-28 Medtronic, Inc. ECAP based control of electrical stimulation therapy
US11129991B2 (en) 2018-06-21 2021-09-28 Medtronic, Inc. ECAP based control of electrical stimulation therapy
US20200269047A1 (en) * 2019-02-21 2020-08-27 Envoy Medical Corporation Implantable cochlear system with integrated components and lead characterization
US11672970B2 (en) 2019-02-21 2023-06-13 Envoy Medical Corporation Implantable cochlear system with integrated components and lead characterization
US11793438B2 (en) 2019-03-29 2023-10-24 Boston Scientific Neuromodulation Corporation Neural sensing in an implantable stimulator device during the provision of active stimulation
US11633138B2 (en) 2019-03-29 2023-04-25 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device in the presence of stimulation artifacts
US11259733B2 (en) 2019-03-29 2022-03-01 Boston Scientific Neuromodulation Corporation Neural sensing in an implantable stimulator device during the provision of active stimulation
US11504526B2 (en) 2019-05-30 2022-11-22 Boston Scientific Neuromodulation Corporation Methods and systems for discrete measurement of electrical characteristics
US11938315B2 (en) 2019-05-30 2024-03-26 Boston Scientific Neuromodulation Corporation Methods and systems for discrete measurement of electrical characteristics
US11623095B2 (en) 2019-06-20 2023-04-11 Boston Scientific Neuromodulation Corporation Methods and systems for interleaving waveforms for electrical stimulation and measurement
US11931582B2 (en) 2019-10-25 2024-03-19 Medtronic, Inc. Managing transient overstimulation based on ECAPs
US11547855B2 (en) 2019-10-25 2023-01-10 Medtronic, Inc. ECAP sensing for high frequency neurostimulation
US11439825B2 (en) 2019-12-19 2022-09-13 Medtronic, Inc. Determining posture state from ECAPs
US11779765B2 (en) 2019-12-19 2023-10-10 Medtronic, Inc. Posture-based control of electrical stimulation therapy
EP3838330A1 (fr) * 2019-12-19 2021-06-23 Oticon Medical A/S Système d'implant cochléaire d'enregistrement d'ecap amélioré
US11813457B2 (en) 2019-12-19 2023-11-14 Medtronic, Inc. Hysteresis compensation for detection of ECAPs
US11202912B2 (en) 2019-12-19 2021-12-21 Medtronic, Inc. Posture-based control of electrical stimulation therapy
US11179567B2 (en) 2019-12-19 2021-11-23 Medtronic, Inc. Hysteresis compensation for detection of ECAPs
US11857793B2 (en) 2020-06-10 2024-01-02 Medtronic, Inc. Managing storage of sensed information
US11564046B2 (en) 2020-08-28 2023-01-24 Envoy Medical Corporation Programming of cochlear implant accessories
US11707626B2 (en) 2020-09-02 2023-07-25 Medtronic, Inc. Analyzing ECAP signals
US11896828B2 (en) 2020-10-30 2024-02-13 Medtronic, Inc. Implantable lead location using ECAP
US11806531B2 (en) 2020-12-02 2023-11-07 Envoy Medical Corporation Implantable cochlear system with inner ear sensor
US11697019B2 (en) 2020-12-02 2023-07-11 Envoy Medical Corporation Combination hearing aid and cochlear implant system
US11471689B2 (en) 2020-12-02 2022-10-18 Envoy Medical Corporation Cochlear implant stimulation calibration
US11839765B2 (en) 2021-02-23 2023-12-12 Envoy Medical Corporation Cochlear implant system with integrated signal analysis functionality
US11633591B2 (en) 2021-02-23 2023-04-25 Envoy Medical Corporation Combination implant system with removable earplug sensor and implanted battery
US11865339B2 (en) 2021-04-05 2024-01-09 Envoy Medical Corporation Cochlear implant system with electrode impedance diagnostics

Similar Documents

Publication Publication Date Title
WO2017100866A1 (fr) Mesure de réponse neuronale
EP0885548B1 (fr) Appareil et procede permettant l&#39;evaluation automatique de parametres de stimulation
US6157861A (en) Self-adjusting cochlear implant system and method for fitting same
EP2167185B1 (fr) Utilisation d&#39;une interaction pour mesurer une excitation neurale
US8190268B2 (en) Automatic measurement of an evoked neural response concurrent with an indication of a psychophysics reaction
EP2688640B1 (fr) Ajustement de prothèse auditive sur la base d&#39;une réponse de muscle auriculaire postérieur
US11491332B2 (en) Cochlear implant system and method for detecting electrode migration using electrically evoked compound action potentials
US8065017B2 (en) Method and apparatus for obtaining and registering an Electrical Cochlear Response (“ECR”)
EP2707092B1 (fr) Constantes de modèles optimaux pour la stimulation simultanée avec compensation d&#39;interaction de canaux
WO2010091177A1 (fr) Configurations de canaux à électrodes multiples
WO2012037305A1 (fr) Procédé et système d&#39;adaptation accélérée d&#39;implants cochléaires basés sur la diffusion du courant
WO2008031169A1 (fr) Procédé de configuration d&#39;un implant médical
US20200093437A1 (en) Eliminating acquisition-related artifacts in electrophysiological recording
CN112891742A (zh) 经由传出神经纤维的耳蜗植入器适配
US20160151629A1 (en) Cochlear implant system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16874157

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16874157

Country of ref document: EP

Kind code of ref document: A1